Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer

BACKGROUND: Women with Down syndrome very rarely develop breast cancer even though they now live to an age when it normally occurs. This may be related to the fact that Down syndrome persons have an additional copy of chromosome 21 where the gene that codes for the antiangiogenic protein Endostatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Retsky, Michael W, Hrushesky, William JM, Gukas, Isaac D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633344/
https://www.ncbi.nlm.nih.gov/pubmed/19133151
http://dx.doi.org/10.1186/1471-2407-9-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633344/
https://www.ncbi.nlm.nih.gov/pubmed/19133151
http://dx.doi.org/10.1186/1471-2407-9-7

Ejemplares similares